Correlation Between Inhibikase Therapeutics and Sio Gene
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and Sio Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and Sio Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and Sio Gene Therapies, you can compare the effects of market volatilities on Inhibikase Therapeutics and Sio Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of Sio Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and Sio Gene.
Diversification Opportunities for Inhibikase Therapeutics and Sio Gene
-0.85 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Inhibikase and Sio is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and Sio Gene Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sio Gene Therapies and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with Sio Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sio Gene Therapies has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and Sio Gene go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and Sio Gene
If you would invest 40.00 in Sio Gene Therapies on August 25, 2024 and sell it today you would earn a total of 0.00 from holding Sio Gene Therapies or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 4.55% |
| Values | Daily Returns |
Inhibikase Therapeutics vs. Sio Gene Therapies
Performance |
| Timeline |
| Inhibikase Therapeutics |
| Sio Gene Therapies |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Inhibikase Therapeutics and Sio Gene Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibikase Therapeutics and Sio Gene
The main advantage of trading using opposite Inhibikase Therapeutics and Sio Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, Sio Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sio Gene will offset losses from the drop in Sio Gene's long position.| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
| Sio Gene vs. CytomX Therapeutics | Sio Gene vs. Assembly Biosciences | Sio Gene vs. Instil Bio | Sio Gene vs. Nuvation Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |